Client sues Russian mobile operator for $500 mln for writing off six minutes of trafficBusiness & Economy August 17, 14:45
Russian government earmarks $67 mln to fight HIVSociety & Culture August 17, 14:42
Man in Moscow charged with human trafficking for trying to sell four womenSociety & Culture August 17, 14:37
Russian football chief rules out Moscow as venue for Russia-Iran friendly matchSport August 17, 14:30
Russia's defense contractor to display new cluster bomb at Army-2017 showMilitary & Defense August 17, 13:41
Press review: Russia boosts military potential and Donbass awaits crucial meetingPress Review August 17, 13:00
Justice Ministry adds Jehovah’s Witnesses to list of organizations outlawed in RussiaWorld August 17, 12:50
Moscow Zoo welcomes pygmy hippopotamus OliviaSociety & Culture August 17, 12:48
Russia’s new MC-21 airliner to climb to 11km altitude in flight testsBusiness & Economy August 17, 12:31
SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- ResMed (NYSE: RMD) today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.
ResMed, a pioneer in the treatment of sleep-disordered breathing (SDB), has been the industry's premier innovator, with award winning customer-centric products that have significantly improved patient acceptance and adherence to SDB therapy.
Ecosystem Approach Brings Increased Efficiency and Efficacy to SDB Treatment
"With Air Solutions, we're creating a new beginning in patient care," said Don Darkin, president of the ResMed Sleep-Disordered Breathing Business Unit. "As we unveil each Air Solutions component, our signature differentiation of superior performance and comfort will be underscored, made even stronger with groundbreaking technology that helps providers become more connected with their patients."
Air Solutions comprises components that, together, create a comprehensive end-to-end ecosystem that directly addresses the pain points for each stakeholder in the patient's therapy, including physicians, sleep labs, home medical equipment providers, and the patients themselves. The ecosystem approach, Darkin says, can increase efficiency and treatment efficacy by keeping providers informed and patients engaged. Included in the Air Solutions platform are:
ApneaLink Air and AirFit masks are available now in the U.S. and other select markets. The AirSense 10 and AirView will be available in the U.S. and Australia on Aug. 18, and other markets later this calendar year. The AirCurve 10 Series and myAir will also be available later this calendar year.
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.
Contact for News Media:
Gretchen Griswold Director, Global Corporate Communications
Contact for Investors:
Agnes Lee Senior Director, Investor Relations